PMDA drug package insert
タコシール組織接着用シート
PMDA Prescription drug · CSLベーリング株式会社 · package insert May 12, 2025
Key facts
| Brand names | タコシール組織接着用シート |
|---|---|
| Nonproprietary names | フィブリノゲン配合剤 |
| Companies | 製造販売（輸入）／CSLベーリング株式会社 |
| Product type | Prescription drug |
| Therapeutic category | シート状生物学的組織接着・閉鎖剤 |
| Therapeutic category codes | 876349 |
| YJ codes | 6349802X3023, 6349802X2027, 6349802X1020 |
| Approval numbers | 22300AMX01210 |
| Package insert edition | 第2版 |
| Package insert date | May 12, 2025 |
| PMDA document key | 100806_6349802X1020_1 |
| PMDA company code | 100806 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: